Chugai Pharmaceutical Co., Ltd.
Chugai Pharmaceutical Co., Ltd. (CHGCY) Stock Competitors & Peer Comparison
See (CHGCY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHGCY | $24.92 | -0.32% | 81.9B | 29.61 | $0.84 | +3.31% |
| BMYMP | $400.00 | -57.46% | 814.6B | 1777.78 | $0.23 | +4.36% |
| RHHBF | $415.00 | -1.94% | 330.3B | 20.22 | $20.52 | +2.81% |
| RHHBY | $51.10 | +0.03% | 329.1B | 19.96 | $2.56 | +3.03% |
| RHHVF | $403.29 | +8.69% | 321B | 19.64 | $20.53 | +3.08% |
| AZNCF | $189.90 | -1.35% | 294.4B | 31.49 | $6.03 | +1.41% |
| NVSEF | $142.65 | -2.12% | 272.2B | 20.44 | $6.98 | +3.32% |
| GLAXF | $25.70 | +0.00% | 102.6B | 13.39 | $1.92 | +3.66% |
| SNYNF | $85.30 | -1.27% | 102.4B | 18.34 | $4.65 | +5.68% |
| CHGCF | $50.91 | +3.90% | 83.8B | 30.31 | $1.68 | +3.54% |
Stock Comparison
CHGCY vs BMYMP Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, BMYMP has a market cap of 814.6B. Regarding current trading prices, CHGCY is priced at $24.92, while BMYMP trades at $400.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas BMYMP's P/E ratio is 1777.78. In terms of profitability, CHGCY's ROE is +0.24%, compared to BMYMP's ROE of +0.39%. Regarding short-term risk, CHGCY is less volatile compared to BMYMP. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check BMYMP's competition here
CHGCY vs RHHBF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, RHHBF has a market cap of 330.3B. Regarding current trading prices, CHGCY is priced at $24.92, while RHHBF trades at $415.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas RHHBF's P/E ratio is 20.22. In terms of profitability, CHGCY's ROE is +0.24%, compared to RHHBF's ROE of +0.29%. Regarding short-term risk, CHGCY is less volatile compared to RHHBF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check RHHBF's competition here
CHGCY vs RHHBY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, RHHBY has a market cap of 329.1B. Regarding current trading prices, CHGCY is priced at $24.92, while RHHBY trades at $51.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas RHHBY's P/E ratio is 19.96. In terms of profitability, CHGCY's ROE is +0.24%, compared to RHHBY's ROE of +0.29%. Regarding short-term risk, CHGCY is more volatile compared to RHHBY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check RHHBY's competition here
CHGCY vs RHHVF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, RHHVF has a market cap of 321B. Regarding current trading prices, CHGCY is priced at $24.92, while RHHVF trades at $403.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas RHHVF's P/E ratio is 19.64. In terms of profitability, CHGCY's ROE is +0.24%, compared to RHHVF's ROE of +0.41%. Regarding short-term risk, CHGCY is less volatile compared to RHHVF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check RHHVF's competition here
CHGCY vs AZNCF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, AZNCF has a market cap of 294.4B. Regarding current trading prices, CHGCY is priced at $24.92, while AZNCF trades at $189.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas AZNCF's P/E ratio is 31.49. In terms of profitability, CHGCY's ROE is +0.24%, compared to AZNCF's ROE of +0.23%. Regarding short-term risk, CHGCY is less volatile compared to AZNCF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check AZNCF's competition here
CHGCY vs NVSEF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, NVSEF has a market cap of 272.2B. Regarding current trading prices, CHGCY is priced at $24.92, while NVSEF trades at $142.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas NVSEF's P/E ratio is 20.44. In terms of profitability, CHGCY's ROE is +0.24%, compared to NVSEF's ROE of +0.32%. Regarding short-term risk, CHGCY is less volatile compared to NVSEF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check NVSEF's competition here
CHGCY vs GLAXF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, GLAXF has a market cap of 102.6B. Regarding current trading prices, CHGCY is priced at $24.92, while GLAXF trades at $25.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas GLAXF's P/E ratio is 13.39. In terms of profitability, CHGCY's ROE is +0.24%, compared to GLAXF's ROE of +0.36%. Regarding short-term risk, CHGCY is more volatile compared to GLAXF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check GLAXF's competition here
CHGCY vs SNYNF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, SNYNF has a market cap of 102.4B. Regarding current trading prices, CHGCY is priced at $24.92, while SNYNF trades at $85.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas SNYNF's P/E ratio is 18.34. In terms of profitability, CHGCY's ROE is +0.24%, compared to SNYNF's ROE of +0.14%. Regarding short-term risk, CHGCY is more volatile compared to SNYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check SNYNF's competition here
CHGCY vs CHGCF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, CHGCF has a market cap of 83.8B. Regarding current trading prices, CHGCY is priced at $24.92, while CHGCF trades at $50.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas CHGCF's P/E ratio is 30.31. In terms of profitability, CHGCY's ROE is +0.24%, compared to CHGCF's ROE of +0.23%. Regarding short-term risk, CHGCY is less volatile compared to CHGCF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check CHGCF's competition here
CHGCY vs BAYRY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, BAYRY has a market cap of 43.1B. Regarding current trading prices, CHGCY is priced at $24.92, while BAYRY trades at $11.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas BAYRY's P/E ratio is -17.14. In terms of profitability, CHGCY's ROE is +0.24%, compared to BAYRY's ROE of -0.07%. Regarding short-term risk, CHGCY is less volatile compared to BAYRY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check BAYRY's competition here
CHGCY vs OTSKY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, OTSKY has a market cap of 37.2B. Regarding current trading prices, CHGCY is priced at $24.92, while OTSKY trades at $35.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas OTSKY's P/E ratio is 16.26. In terms of profitability, CHGCY's ROE is +0.24%, compared to OTSKY's ROE of +0.13%. Regarding short-term risk, CHGCY is more volatile compared to OTSKY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check OTSKY's competition here
CHGCY vs OTSKF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, OTSKF has a market cap of 34B. Regarding current trading prices, CHGCY is priced at $24.92, while OTSKF trades at $64.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas OTSKF's P/E ratio is 14.88. In terms of profitability, CHGCY's ROE is +0.24%, compared to OTSKF's ROE of +0.13%. Regarding short-term risk, CHGCY is more volatile compared to OTSKF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check OTSKF's competition here
CHGCY vs DSKYF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, DSKYF has a market cap of 30.7B. Regarding current trading prices, CHGCY is priced at $24.92, while DSKYF trades at $16.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas DSKYF's P/E ratio is 18.98. In terms of profitability, CHGCY's ROE is +0.24%, compared to DSKYF's ROE of +0.16%. Regarding short-term risk, CHGCY is less volatile compared to DSKYF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check DSKYF's competition here
CHGCY vs DSNKY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, DSNKY has a market cap of 29.9B. Regarding current trading prices, CHGCY is priced at $24.92, while DSNKY trades at $16.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas DSNKY's P/E ratio is 18.48. In terms of profitability, CHGCY's ROE is +0.24%, compared to DSNKY's ROE of +0.16%. Regarding short-term risk, CHGCY is less volatile compared to DSNKY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check DSNKY's competition here
CHGCY vs ALPMF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, ALPMF has a market cap of 28B. Regarding current trading prices, CHGCY is priced at $24.92, while ALPMF trades at $15.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas ALPMF's P/E ratio is 15.19. In terms of profitability, CHGCY's ROE is +0.24%, compared to ALPMF's ROE of +0.17%. Regarding short-term risk, CHGCY is more volatile compared to ALPMF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check ALPMF's competition here
CHGCY vs ALPMY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, ALPMY has a market cap of 25.9B. Regarding current trading prices, CHGCY is priced at $24.92, while ALPMY trades at $14.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas ALPMY's P/E ratio is 14.03. In terms of profitability, CHGCY's ROE is +0.24%, compared to ALPMY's ROE of +0.18%. Regarding short-term risk, CHGCY is less volatile compared to ALPMY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check ALPMY's competition here
CHGCY vs ORINY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, ORINY has a market cap of 22.7B. Regarding current trading prices, CHGCY is priced at $24.92, while ORINY trades at $40.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas ORINY's P/E ratio is 18.30. In terms of profitability, CHGCY's ROE is +0.24%, compared to ORINY's ROE of +0.49%. Regarding short-term risk, CHGCY is more volatile compared to ORINY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check ORINY's competition here
CHGCY vs GIKLY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, GIKLY has a market cap of 13.9B. Regarding current trading prices, CHGCY is priced at $24.92, while GIKLY trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas GIKLY's P/E ratio is 14.72. In terms of profitability, CHGCY's ROE is +0.24%, compared to GIKLY's ROE of +0.08%. Regarding short-term risk, CHGCY is more volatile compared to GIKLY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check GIKLY's competition here
CHGCY vs CHJTF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, CHJTF has a market cap of 12B. Regarding current trading prices, CHGCY is priced at $24.92, while CHJTF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas CHJTF's P/E ratio is 21.00. In terms of profitability, CHGCY's ROE is +0.24%, compared to CHJTF's ROE of +0.05%. Regarding short-term risk, CHGCY is more volatile compared to CHJTF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check CHJTF's competition here
CHGCY vs ORINF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, ORINF has a market cap of 11.7B. Regarding current trading prices, CHGCY is priced at $24.92, while ORINF trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas ORINF's P/E ratio is 18.81. In terms of profitability, CHGCY's ROE is +0.24%, compared to ORINF's ROE of +0.49%. Regarding short-term risk, CHGCY is more volatile compared to ORINF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check ORINF's competition here
CHGCY vs CSPCY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, CSPCY has a market cap of 11.1B. Regarding current trading prices, CHGCY is priced at $24.92, while CSPCY trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas CSPCY's P/E ratio is 19.30. In terms of profitability, CHGCY's ROE is +0.24%, compared to CSPCY's ROE of +0.05%. Regarding short-term risk, CHGCY is less volatile compared to CSPCY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check CSPCY's competition here
CHGCY vs RCDTF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, RCDTF has a market cap of 10B. Regarding current trading prices, CHGCY is priced at $24.92, while RCDTF trades at $49.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas RCDTF's P/E ratio is 18.56. In terms of profitability, CHGCY's ROE is +0.24%, compared to RCDTF's ROE of +0.24%. Regarding short-term risk, CHGCY is less volatile compared to RCDTF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check RCDTF's competition here
CHGCY vs GIFOF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, GIFOF has a market cap of 8.7B. Regarding current trading prices, CHGCY is priced at $24.92, while GIFOF trades at $8.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas GIFOF's P/E ratio is 12.46. In terms of profitability, CHGCY's ROE is +0.24%, compared to GIFOF's ROE of +0.08%. Regarding short-term risk, CHGCY is more volatile compared to GIFOF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check GIFOF's competition here
CHGCY vs GIFLF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, GIFLF has a market cap of 7.2B. Regarding current trading prices, CHGCY is priced at $24.92, while GIFLF trades at $10.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas GIFLF's P/E ratio is 14.89. In terms of profitability, CHGCY's ROE is +0.24%, compared to GIFLF's ROE of +0.08%. Regarding short-term risk, CHGCY is more volatile compared to GIFLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check GIFLF's competition here
CHGCY vs OPHLY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, OPHLY has a market cap of 7.2B. Regarding current trading prices, CHGCY is priced at $24.92, while OPHLY trades at $5.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas OPHLY's P/E ratio is 16.42. In terms of profitability, CHGCY's ROE is +0.24%, compared to OPHLY's ROE of +0.09%. Regarding short-term risk, CHGCY is less volatile compared to OPHLY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check OPHLY's competition here
CHGCY vs OPHLF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, OPHLF has a market cap of 6.8B. Regarding current trading prices, CHGCY is priced at $24.92, while OPHLF trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas OPHLF's P/E ratio is 15.48. In terms of profitability, CHGCY's ROE is +0.24%, compared to OPHLF's ROE of +0.09%. Regarding short-term risk, CHGCY is more volatile compared to OPHLF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check OPHLF's competition here
CHGCY vs KYKOF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, KYKOF has a market cap of 6.7B. Regarding current trading prices, CHGCY is priced at $24.92, while KYKOF trades at $12.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas KYKOF's P/E ratio is 15.85. In terms of profitability, CHGCY's ROE is +0.24%, compared to KYKOF's ROE of +0.08%. Regarding short-term risk, CHGCY is more volatile compared to KYKOF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check KYKOF's competition here
CHGCY vs DPHAY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, DPHAY has a market cap of 5.6B. Regarding current trading prices, CHGCY is priced at $24.92, while DPHAY trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas DPHAY's P/E ratio is -155.56. In terms of profitability, CHGCY's ROE is +0.24%, compared to DPHAY's ROE of -0.04%. Regarding short-term risk, CHGCY is more volatile compared to DPHAY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check DPHAY's competition here
CHGCY vs SNPHY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, SNPHY has a market cap of 3.7B. Regarding current trading prices, CHGCY is priced at $24.92, while SNPHY trades at $11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas SNPHY's P/E ratio is 16.15. In terms of profitability, CHGCY's ROE is +0.24%, compared to SNPHY's ROE of +0.13%. Regarding short-term risk, CHGCY is less volatile compared to SNPHY. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check SNPHY's competition here
CHGCY vs VRBCF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, VRBCF has a market cap of 3.6B. Regarding current trading prices, CHGCY is priced at $24.92, while VRBCF trades at $431.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas VRBCF's P/E ratio is 20.47. In terms of profitability, CHGCY's ROE is +0.24%, compared to VRBCF's ROE of +0.14%. Regarding short-term risk, CHGCY is more volatile compared to VRBCF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check VRBCF's competition here
CHGCY vs SNPHF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, SNPHF has a market cap of 3.5B. Regarding current trading prices, CHGCY is priced at $24.92, while SNPHF trades at $10.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas SNPHF's P/E ratio is 15.26. In terms of profitability, CHGCY's ROE is +0.24%, compared to SNPHF's ROE of +0.17%. Regarding short-term risk, CHGCY is more volatile compared to SNPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check SNPHF's competition here
CHGCY vs HAWPY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, HAWPY has a market cap of 3B. Regarding current trading prices, CHGCY is priced at $24.92, while HAWPY trades at $54.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas HAWPY's P/E ratio is 14.44. In terms of profitability, CHGCY's ROE is +0.24%, compared to HAWPY's ROE of +0.06%. Regarding short-term risk, CHGCY is more volatile compared to HAWPY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check HAWPY's competition here
CHGCY vs HAWPF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, HAWPF has a market cap of 2.7B. Regarding current trading prices, CHGCY is priced at $24.92, while HAWPF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas HAWPF's P/E ratio is 12.77. In terms of profitability, CHGCY's ROE is +0.24%, compared to HAWPF's ROE of +0.06%. Regarding short-term risk, CHGCY is less volatile compared to HAWPF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check HAWPF's competition here
CHGCY vs PTKFF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, PTKFF has a market cap of 2.2B. Regarding current trading prices, CHGCY is priced at $24.92, while PTKFF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas PTKFF's P/E ratio is N/A. In terms of profitability, CHGCY's ROE is +0.24%, compared to PTKFF's ROE of +0.16%. Regarding short-term risk, CHGCY is more volatile compared to PTKFF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check PTKFF's competition here
CHGCY vs LYPHF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, LYPHF has a market cap of 1.3B. Regarding current trading prices, CHGCY is priced at $24.92, while LYPHF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas LYPHF's P/E ratio is 16.39. In terms of profitability, CHGCY's ROE is +0.24%, compared to LYPHF's ROE of +0.04%. Regarding short-term risk, CHGCY is more volatile compared to LYPHF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check LYPHF's competition here
CHGCY vs TGRNF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, TGRNF has a market cap of 633.9M. Regarding current trading prices, CHGCY is priced at $24.92, while TGRNF trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas TGRNF's P/E ratio is 9.90. In terms of profitability, CHGCY's ROE is +0.24%, compared to TGRNF's ROE of +0.05%. Regarding short-term risk, CHGCY is more volatile compared to TGRNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check TGRNF's competition here
CHGCY vs JCRRF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, JCRRF has a market cap of 508.7M. Regarding current trading prices, CHGCY is priced at $24.92, while JCRRF trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas JCRRF's P/E ratio is -34.75. In terms of profitability, CHGCY's ROE is +0.24%, compared to JCRRF's ROE of +0.06%. Regarding short-term risk, CHGCY is more volatile compared to JCRRF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check JCRRF's competition here
CHGCY vs MAYNF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, MAYNF has a market cap of 138.8M. Regarding current trading prices, CHGCY is priced at $24.92, while MAYNF trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas MAYNF's P/E ratio is -2.25. In terms of profitability, CHGCY's ROE is +0.24%, compared to MAYNF's ROE of -0.23%. Regarding short-term risk, CHGCY is more volatile compared to MAYNF. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check MAYNF's competition here
CHGCY vs PTKFY Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, PTKFY has a market cap of 11M. Regarding current trading prices, CHGCY is priced at $24.92, while PTKFY trades at $9.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas PTKFY's P/E ratio is 10.69. In terms of profitability, CHGCY's ROE is +0.24%, compared to PTKFY's ROE of +0.16%. Regarding short-term risk, CHGCY is more volatile compared to PTKFY. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check PTKFY's competition here
CHGCY vs PSYGF Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, PSYGF has a market cap of 2.2M. Regarding current trading prices, CHGCY is priced at $24.92, while PSYGF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas PSYGF's P/E ratio is -0.19. In terms of profitability, CHGCY's ROE is +0.24%, compared to PSYGF's ROE of -14.36%. Regarding short-term risk, CHGCY is less volatile compared to PSYGF. This indicates potentially lower risk in terms of short-term price fluctuations for CHGCY.Check PSYGF's competition here
CHGCY vs CRXTQ Comparison May 2026
CHGCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHGCY stands at 81.9B. In comparison, CRXTQ has a market cap of 72.8K. Regarding current trading prices, CHGCY is priced at $24.92, while CRXTQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHGCY currently has a P/E ratio of 29.61, whereas CRXTQ's P/E ratio is -0.00. In terms of profitability, CHGCY's ROE is +0.24%, compared to CRXTQ's ROE of +0.33%. Regarding short-term risk, CHGCY is more volatile compared to CRXTQ. This indicates potentially higher risk in terms of short-term price fluctuations for CHGCY.Check CRXTQ's competition here